As of 2026-07-04, the Intrinsic Value of Beyond Medical Technologies Inc (DOCT.CN) is -1.06 CAD. This DOCT.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.13 CAD, the upside of Beyond Medical Technologies Inc is -951.41%.
Based on its market price of 0.13 CAD and our intrinsic valuation, Beyond Medical Technologies Inc (DOCT.CN) is overvalued by 951.41%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.06 - -1.06 | -1.06 | -951.41% |
| DDM - Stable | (0.38) - (0.82) | (0.60) | -579.5% |
| DDM - Multi | (0.22) - (0.37) | (0.28) | -320.6% |
| Market Cap (mil) | 4.06 |
| Beta | 2.16 |
| Outstanding shares (mil) | 32.49 |
| Enterprise Value (mil) | 3.16 |
| Market risk premium | 5.10% |
| Cost of Equity | 13.70% |
| Cost of Debt | 5.00% |
| WACC | 13.54% |